Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow

J. Amedee, R. Bareille, F. Rouais, N. Cunningham, A Hari Reddi, M. F. Harmand

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Treatment of human bone marrow osteoprogenitors with osteogenin (BMP-3; at 1, 2.5 and 10 ng/ml) caused dose- and time-dependent inhibition of DNA synthesis and cell proliferation. Simultaneously, osteogenin stimulated type I collagen synthesis and cAMP production. Addition of osteogenin to the cell culture increased intracellular alkaline phosphatase activity and osteocalcin synthesis, with maximal stimulation at 2.5 ng/ml. Simultaneous addition of 2.5 ng/ml osteogenin and 1,25 dihydroxy vitamin D3 (10-8 M) enhanced the stimulation observed in osteocalcin synthesis. The experiments reported here demonstrate the significant 'in vitro' influence of osteogenin in the stimulation of osteogenic phenotype in osteoprogenitor cells which have been isolated from human bone marrow and cloned. These results support a reciprocal relationship between cell growth inhibition and expression of osteoblast differentiation.

Original languageEnglish (US)
Pages (from-to)157-164
Number of pages8
JournalDifferentiation
Volume58
Issue number2
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Bone Morphogenetic Protein 3
Bone Marrow
Bone and Bones
Osteocalcin
Proteins
Collagen Type I
Osteoblasts
Alkaline Phosphatase
Cell Culture Techniques
Cell Proliferation
Phenotype
DNA
Growth

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Developmental Biology
  • Cell Biology

Cite this

Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow. / Amedee, J.; Bareille, R.; Rouais, F.; Cunningham, N.; Reddi, A Hari; Harmand, M. F.

In: Differentiation, Vol. 58, No. 2, 1995, p. 157-164.

Research output: Contribution to journalArticle

Amedee, J. ; Bareille, R. ; Rouais, F. ; Cunningham, N. ; Reddi, A Hari ; Harmand, M. F. / Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow. In: Differentiation. 1995 ; Vol. 58, No. 2. pp. 157-164.
@article{ca7606aacc6e480c8e2eefd41508dccc,
title = "Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow",
abstract = "Treatment of human bone marrow osteoprogenitors with osteogenin (BMP-3; at 1, 2.5 and 10 ng/ml) caused dose- and time-dependent inhibition of DNA synthesis and cell proliferation. Simultaneously, osteogenin stimulated type I collagen synthesis and cAMP production. Addition of osteogenin to the cell culture increased intracellular alkaline phosphatase activity and osteocalcin synthesis, with maximal stimulation at 2.5 ng/ml. Simultaneous addition of 2.5 ng/ml osteogenin and 1,25 dihydroxy vitamin D3 (10-8 M) enhanced the stimulation observed in osteocalcin synthesis. The experiments reported here demonstrate the significant 'in vitro' influence of osteogenin in the stimulation of osteogenic phenotype in osteoprogenitor cells which have been isolated from human bone marrow and cloned. These results support a reciprocal relationship between cell growth inhibition and expression of osteoblast differentiation.",
author = "J. Amedee and R. Bareille and F. Rouais and N. Cunningham and Reddi, {A Hari} and Harmand, {M. F.}",
year = "1995",
doi = "10.1007/s002580050074",
language = "English (US)",
volume = "58",
pages = "157--164",
journal = "Differentiation",
issn = "0301-4681",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow

AU - Amedee, J.

AU - Bareille, R.

AU - Rouais, F.

AU - Cunningham, N.

AU - Reddi, A Hari

AU - Harmand, M. F.

PY - 1995

Y1 - 1995

N2 - Treatment of human bone marrow osteoprogenitors with osteogenin (BMP-3; at 1, 2.5 and 10 ng/ml) caused dose- and time-dependent inhibition of DNA synthesis and cell proliferation. Simultaneously, osteogenin stimulated type I collagen synthesis and cAMP production. Addition of osteogenin to the cell culture increased intracellular alkaline phosphatase activity and osteocalcin synthesis, with maximal stimulation at 2.5 ng/ml. Simultaneous addition of 2.5 ng/ml osteogenin and 1,25 dihydroxy vitamin D3 (10-8 M) enhanced the stimulation observed in osteocalcin synthesis. The experiments reported here demonstrate the significant 'in vitro' influence of osteogenin in the stimulation of osteogenic phenotype in osteoprogenitor cells which have been isolated from human bone marrow and cloned. These results support a reciprocal relationship between cell growth inhibition and expression of osteoblast differentiation.

AB - Treatment of human bone marrow osteoprogenitors with osteogenin (BMP-3; at 1, 2.5 and 10 ng/ml) caused dose- and time-dependent inhibition of DNA synthesis and cell proliferation. Simultaneously, osteogenin stimulated type I collagen synthesis and cAMP production. Addition of osteogenin to the cell culture increased intracellular alkaline phosphatase activity and osteocalcin synthesis, with maximal stimulation at 2.5 ng/ml. Simultaneous addition of 2.5 ng/ml osteogenin and 1,25 dihydroxy vitamin D3 (10-8 M) enhanced the stimulation observed in osteocalcin synthesis. The experiments reported here demonstrate the significant 'in vitro' influence of osteogenin in the stimulation of osteogenic phenotype in osteoprogenitor cells which have been isolated from human bone marrow and cloned. These results support a reciprocal relationship between cell growth inhibition and expression of osteoblast differentiation.

UR - http://www.scopus.com/inward/record.url?scp=0028582171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028582171&partnerID=8YFLogxK

U2 - 10.1007/s002580050074

DO - 10.1007/s002580050074

M3 - Article

C2 - 7890141

AN - SCOPUS:0028582171

VL - 58

SP - 157

EP - 164

JO - Differentiation

JF - Differentiation

SN - 0301-4681

IS - 2

ER -